Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 2
2006 2
2007 4
2008 4
2009 8
2010 4
2011 4
2012 3
2013 4
2014 1
2015 3
2016 3
2017 2
2018 2
2019 7
2020 11
2021 5
2022 7
2023 8
2024 13
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
Meyer Sauteur PM, Beeton ML; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Meyer Sauteur PM, et al. Lancet Microbe. 2024 Feb;5(2):e100-e101. doi: 10.1016/S2666-5247(23)00344-0. Epub 2023 Nov 23. Lancet Microbe. 2024. PMID: 38008103 Free article. No abstract available.
Mycoplasma pneumoniae: gone forever?
Meyer Sauteur PM, Beeton ML; ESGMAC the ESGMAC MAPS study group. Meyer Sauteur PM, et al. Lancet Microbe. 2023 Oct;4(10):e763. doi: 10.1016/S2666-5247(23)00182-9. Epub 2023 Jun 29. Lancet Microbe. 2023. PMID: 37393927 Free article. No abstract available.
Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae.
Meyer Sauteur PM, Beeton ML; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Meyer Sauteur PM, et al. Lancet Microbe. 2024 Jun;5(6):e514. doi: 10.1016/S2666-5247(23)00406-8. Epub 2024 Feb 8. Lancet Microbe. 2024. PMID: 38342111 Free article. No abstract available.
Mycoplasma pneumoniae: re-emergence and beyond.
Meyer Sauteur PM; European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) Mycoplasma pneumoniae Surveillance (MAPS) study group. Meyer Sauteur PM, et al. Lancet Microbe. 2025 Jul 16:101191. doi: 10.1016/j.lanmic.2025.101191. Online ahead of print. Lancet Microbe. 2025. PMID: 40683283 Free article. No abstract available.
Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.
Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, Pereyre S, Bébéar C, Keše D, Day J, Afshar B, Chalker VJ, Greub G, Nir-Paz R, Dumke R; ESGMAC–MyCOVID Study Team. Meyer Sauteur PM, et al. Euro Surveill. 2022 May;27(19):2100746. doi: 10.2807/1560-7917.ES.2022.27.19.2100746. Euro Surveill. 2022. PMID: 35551702 Free PMC article.
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025.
Rose AM, Lucaccioni H, Marsh K, Kirsebom F, Whitaker H, Emborg HD, Bolt Botnen A, O'Doherty MG, Pozo F, Hameed SS, Andrews N, Hamilton M, Trebbien R, Lauenborg Møller K, Marques DF, Murphy S, McQueenie R, Lopez-Bernal J, Cottrell S, Bucholc M, Kissling E; European IVE group; Members of the European IVE group. Rose AM, et al. Among authors: emborg hd. Euro Surveill. 2025 Feb;30(7):2500102. doi: 10.2807/1560-7917.ES.2025.30.7.2500102. Euro Surveill. 2025. PMID: 39980423 Free PMC article.
Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort study.
Dungu KHS, Holm M, Hartling U, Jensen LH, Nielsen AB, Schmidt LS, Toustrup LB, Hansen LH, Dahl KW, Matthesen KT, Nordholm AC, Uldum S, Emborg HD, Rytter MJH, Nygaard U. Dungu KHS, et al. Among authors: emborg hd. Lancet Reg Health Eur. 2024 Oct 18;47:101103. doi: 10.1016/j.lanepe.2024.101103. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39469091 Free PMC article.
Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022.
Colombe S, Funke S, Koch A, Haverkate M, Monge S, Barret AS, Vaughan A, Hahné S, van Ewijk C, Emborg HD, von Schreeb S, Díaz A, Olmedo C, Zanetti L, Levy-Bruhl D, de Sousa LA, Hagan J, Nicolay N, Pebody R. Colombe S, et al. Among authors: emborg hd. Euro Surveill. 2024 Aug;29(34):2400139. doi: 10.2807/1560-7917.ES.2024.29.34.2400139. Euro Surveill. 2024. PMID: 39176988 Free PMC article.
New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic.
Teirlinck AC, Johannesen CK, Broberg EK, Penttinen P, Campbell H, Nair H, Reeves RM, Bøås H, Brytting M, Cai W, Carnahan A, Casalegno JS, Danis K, De Gascun C, Ellis J, Emborg HD, Gijon M, Guiomar R, Hirve SS, Jiřincová H, Nohynek H, Oliva JA, Osei-Yeboah R, Paget J, Pakarna G, Pebody R, Presser L, Rapp M, Reiche J, Rodrigues AP, Seppälä E, Socan M, Szymanski K, Trebbien R, Večeřová J, van der Werf S, Zambon M, Meijer A, Fischer TK. Teirlinck AC, et al. Among authors: emborg hd. Eur Respir J. 2023 Apr 3;61(4):2201569. doi: 10.1183/13993003.01569-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 37012081 Free PMC article.
97 results